The gut-brain axis: A major glucoregulatory player;L'interrelation intestin-cerveau, un axe régulateur métabolique majeur

Diabetes and Metabolism

Volumn 36, Issue SUPPL. 3, 2010, Pages

  Burcelin, R ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Autonomic nervous system; Diabetes; Incretins; Review

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; BLOOD VESSEL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INTESTINE INNERVATION; LIVER; MUSCLE; NUTRIENT; PANCREAS; PANCREAS ISLET BETA CELL; SENSOR; SIGNAL TRANSDUCTION; VAGUS NERVE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BRAIN; DIABETES MELLITUS; GLUCOSE; HUMANS; INCRETINS; INTESTINES; SIGNAL TRANSDUCTION;

EID: 78650774089     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(10)70468-7     Document Type: Article

References (45)

1. Adachi A., Shimizu N., Oomura Y., Kobashi M. Convergence of hepatoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci Lett 1984, 46:215-218.
2. Jungermann K., Gardemann A., Beuers U., Balle C., Sannemann J., Beckh K., et al. Regulation of liver metabolism by the hepatic nerves. Advances in Enzyme Regulation 1987, 26:63-88.
3. Burcelin R. The incretins: a link between nutrients and well-being. Br J Nutr 2005, 93(suppl 1):S147-S156.
4. Burcelin R., Dolci W., Thorens B. Portal glucose infusion in the mouse induces hypoglycemia. Evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 2000, 49:1635-1642.
5. Russek M. Demonstration of the influence of an hepatic glucosensitive mechanism on food-intake. Physiol Behav 1970, 10:1207-1209.
6. Knauf C., Cani P.D., Kim D.H., Iglesias M.A., Chabo C., Waget A., et al. Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. Diabetes 2008, 57:2603-2612.
7. Nakabayashi H., Kobayashi K., Nakabayashi I., Kurata Y. Somatostatin receptor on the afferent nerve terminals in the rat hepatoportal area. Neurosci Lett 1995, 183:46-49.
8. Niijima A., Fukuda A., Taguchi T., Okuda J. Suppression of afferent activity of the hepatic vagus nerve by anomers of D-glucose. Am J Physiol 1983, 244:R611-R614.
9. Niijima A. Afferent impulse discharges from glucoreceptors in the liver of the guinea pig. Ann N Y Acad Sci 1969, 157:690-700.
10. Hevener A., Bergman R., Donovan C. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 2000, 49:8-12.
11. Hevener A.L., Bergman R.N., Donovan C.M. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 1997, 46:1521-1525.
12. Stumpel F., Jungermann K. Sensing by intrahepatic muscarinic nerves of a portal-arterial glucose concentration gradient as a signal for insulin-dependent glucose uptake in the perfused rat liver. FEBS Letters 1997, 406:119-122.
13. Stumpel F., Scholtka B., Jungermann K. Impaired glucose sensing by intrahepatic, muscarinic nerves for an insulin-stimulated hepatic glucose uptake in streptozotocin-diabetic rats. FEBS Letters 1998, 436:185-188.
14. Myers S.R., Biggers D.W., Neal D.W., Cherrington A.D. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest 1991, 88:158-167.
15. Moore M.C., Shulman G.I., Giaccari A., Pagliassotti M.J., Cline G., Neal D., et al. Effect of hepatic nerves on disposition of an intraduodenal glucose load. Am J Physiol 1993, 265:E487-E496.
16. Moore M.C., Satake S., Baranowski B., Hsieh P.S., Neal D.W., Cherrington A.D. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab 2002, 282:E286-E296.
17. Burcelin R., Crivelli V., Perrin C., Da Costa A., Mu J., Kahn B.B., et al. GLUT4. AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J Clin Invest 2003, 111:1555-1562.
18. Dyer J., Vayro S., Shirazi-Beechey S.P. Mechanism of glucose sensing in the small intestine. Biochem Soc Trans 2003, 31:1140-1142.
19. Matschinsky F.M. A lesson in metabolic regulation inspired by the glucokinase paradigm. Diabetes 1996, 45:223-241.
20. Matschinsky F.M. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes 2002, 51(Suppl 3):S394-S404.
21. Phillips R., Powley T. Innervation of the gastrointestinal tract: patterns of aging. Auton Neurosci 2007, 136:1-19.
22. Niijima A. Electrophysiological study on nervous pathway from splanchnic nerve to vagus nerve in rat. Am J Physiol 1983, 244:R888-R890.
23. Niijima A. Glucose-sensitive afferent nerve fibers in the liver and their role in food intake and blood glucose regulation. J Auton Nerv Syst 1983, 9:207-220.
24. Niijima A. Effect of glucose and other hexoses on efferent discharges of brown adipose tissue nerves. Am J Physiol 1986, 251:R240-R242.
25. Bassotti G., Villanacci V., Fisogni S., Rossi E., Baronio P., Clerici C., et al. Enteric glial cells and their role in gastrointestinal motor abnormalities: introducing the neuro-gliopathies. World J Gastroenterol 2007, 13:4035-4041.
26. Burcelin R., Dolci W., Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2 dependent. In vivo analysis in GLUT-2null mice. Diabetes 2000, 49:1643-1648.
27. Dardevet D., Moore M.C., Neal D., DiCostanzo C.A., Snead W., Cherrington A.D. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. Am J Physiol Endocrinol Metab 2004, 287:E75-E81.
28. Burcelin R., Da Costa A., Drucker D., Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 2001, 50:1720-1728.
29. Johnson K.M., Edgerton D.S., Rodewald T., Scott M., Farmer B., Neal D., et al. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels. Am J Physiol Endocrinol Metab 2007, 293:E1085-E1091.
30. Nishizawa M., Moore M.C., Shiota M., Gustavson S.M., Snead W.L., Neal D.W., et al. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs. Am J Physiol Endocrinol Metab 2003, 284:E1027-E1036.
31. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. USA 1992, 89:8641-8645.
32. Gremlich S., Porret A., Hani E.H., Cherif D., Vionnet N., Froguel P., et al. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 1995, 44:1202-1208.
33. Zunz E., La Barre J. Contributions à l'étude des variations physiologiques de la sécrétion interne du pancréas: relations entre les sécretions externe et interne du pancréas. Arch Int Physiol Biochim Biophys Acta 1929, 31:20-44.
34. Holst J.J. Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity. Diabetologia 1977, 13:159-169.
35. Deacon C.F., Nauck M.A., Toft-Nielsen M., Pridal L., Willms B., Holst J.J. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 1995, 44:1126-1131.
36. Deacon C.F., Johnsen A.H., Holst J.J. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 1995, 80:952-957.
37. Yasuda N., Inoue T., Nagakura T., Yamazaki K., Kira K., Saeki T., et al. Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. Biochem Biophys Res Commun 2002, 298:779-784.
38. Ruttimann E.B., Arnold M., Hillebrand J.J., Geary N., Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagonlike peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009, 150:1174-1181.
39. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005, 1044:127-131.
40. Hansen L., Lampert S., Mineo H., Holst J.J. Neural regulation of glucagon-like peptide-1 secretion in pigs. Am J Physiol Endocrinol Metab 2004, 287:E939-E947.
41. Barragan J.M., Eng J., Rodriguez R., Blazquez E. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol 1999, 277:E784-E791.
42. Imeryuz N., Yegen B.C., Bozkurt A., Coskun T., Villanueva-Penacarrillo M.L., Ulusoy N.B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol 1997, 273:G920-G927.
43. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am. J. Physiol 1996, 271:E808-E813.
44. Cabou C., Campistron G., Marsollier N., Leloup C., Cruciani-Guglielmacci C., Pénicaud L., et al. Brain GLP-1 regulates arterial blood flow, heart rate and insulin sensitivity. Diabetes 2008, 57:2577-2587.
45. Cabou C., Cani P.D., Campistron G., Knauf C., Mathieu C., Sartori C., et al. Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes 2007, 56:2872-2877.